Shortwave Diathermy and Pilates Exercises in Patients With Chronic Non-specific Low Back

October 1, 2020 updated by: Raquel A. Casarotto, University of Sao Paulo General Hospital

Effects of Shortwave Diathermy and Pilates Exercises in Patients With Chronic Non-specific Low Back Pain: a Protocol of a Randomized Controlled Trial

The aim of this study is to verify the effectiveness of the association of Shortwave Diathermy and Pilates exercises in patients with chronic non-specific low back pain, on the reduction of pain, functional disability and improvement of the quality of life.

Study Overview

Detailed Description

The drawing of the study will be a prospective, randomized controlled trial and double-blind with quantitative approach. Study participants 36 subjects diagnosed with non-specific chronic low back pain, which will be divided in two groups with 18 subjects in each: experimental group, which will be submitted to placebo + exercise shortwave diathermy and the control group to do active + exercise shortwave diathermy. There will be 12 one-hour sessions twice a week. The subjects will apply Shortwave Diathermy for 20 minutes, followed by Pilates mat.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • São Paulo, Brazil, 05360-160
        • Department of Physical Therapy, Speech and Occupational Therapy of University of São Paulo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • individuals diagnosed with chronic non-specific low back pain for a period of more than 3 months, without irradiation for lower limbs;
  • who present pain intensity greater than 3 points in the Numerical Pain Scale;
  • to sign the Free and Informed Consent Form.

Exclusion Criteria:

  • BMI> 30;
  • previous surgeries in the spine;
  • severe spinal affection (tumors, infection, unconsolidated or vicious consolidation fractures, inflammatory diseases);
  • rheumatic disease;
  • contraindication to performing the exercises according to the American College of Sports Medicine Guidelines;
  • degenerative or inflammatory joint and other body segments;
  • patients who are in labor litigation;
  • pregnancy;
  • patients who are undergoing other type of physiotherapeutic or drug treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Pilates and Shortwave placebo
In this group the patients will receive 20 minutes of short wave placebo application. The equipment will keep the timer on and the intensity will remain at zero. The patient will be informed that the dose is subsensory and therefore there will be no perception of the passage of the short waves through the body.The application will be performed with two coplanar plates in parallel, arranged on the right and left side of the lumbar region, maintaining a distance of 5 to 10 cm between them, with the patient lying in the dorsal decubitus position
Pilates exercises and application of the device without produce thermal effects
Active Comparator: Pilates and Shortwave active
In this group the patients will receive 20 minutes of application of the Shortwave Active continuous mode (thermal effect), with vigorous local thermal sensation.The application will be performed with two coplanar plates in parallel, arranged on the right and left side of the lumbar region, maintaining a distance of 5 to 10 cm between them, with the patient lying in the dorsal decubitus position
Pilates exercises and application of the device producing thermal effects

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain through Pain visual analogue scale
Time Frame: Before the treatment, up to 3, 6 and 18 weeks
Scale with 11 centimeters is used for evaluate pain intensity, being "0" no pain and "10" the worst possible pain
Before the treatment, up to 3, 6 and 18 weeks
Change in pain through The McGill pain questionnaire
Time Frame: Before the treatment, up to 3, 6 and 18 weeks
It is organized in four categories: sensory, affective, evaluative and mixed, with 20 subcategories and 78 words descriptors of pain, describing the quality of pain. The pain evaluation index is the sum of the values added, and each word chosen in each dimension is the maximum score of each category: Sensory = 34, Affective = 17, Evaluative = 5, Mixed = 11, Total = 67.
Before the treatment, up to 3, 6 and 18 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional disability
Time Frame: Before the treatment, up to 3, 6 and 18 weeks
The Rolland and Morris Questionnaire, validated in Brazil, will quantify the functional limitations caused by low back pain. The questionnaire is composed of 24 questions related to normal activities of daily living, in which each affirmative answer corresponds to a point. The final score is determined by the sum of the values obtained. Values close to zero represent the best results (lower limitation), and values close to 24 the worst results. Values above 14 points are considered as a severe spinal impairment.
Before the treatment, up to 3, 6 and 18 weeks
Patients' perceptions of their health-related quality of life: The Short-Form Health Survey questionnaire (SF-36)
Time Frame: Before the treatment, up to 3, 6 and 18 weeks
The Short-Form Health Survey questionnaire (SF-36) will assess the health-related quality of life of patients. This instrument contains 36 questions grouped into eight areas: functional capacity (10 items), physical aspects (2 items), pain (2 items), general state of health (5 items), vitality (4 items), social aspects (2 items), emotional (3 items) and mental health (5 items). The values in each domain vary from 0 to 100 and, more indicate a better quality of life.
Before the treatment, up to 3, 6 and 18 weeks
Perception of global effect
Time Frame: Before the treatment, up to 3, 6 and 18 weeks
Evaluates the level of perception of patient recovery through a Scale Numbers of 11 points comparing the onset of symptoms at the beginning of treatment in relation to the last days. It varies from -5 to +5, being -5: extremely worse; zero: no modification; and +5: fully recovered, with the highest score representing greater recovery.
Before the treatment, up to 3, 6 and 18 weeks
Emotional Functioning
Time Frame: Before the treatment, up to 3, 6 and 18 weeks
It will be evaluated by the Brazilian version of the Visual Analog Scale for anxiety. Analogic visual scale for anxiety is a horizontal line of 100 mm in length. The tip left without anxiety and the right tip means worse anxiety.
Before the treatment, up to 3, 6 and 18 weeks
Depressive Symptom
Time Frame: Before the treatment, up to 3, 6 and 18 weeks
It will be evaluated by the Brazilian version of the Beck Depression Inventory, a self-assessment measure of depression. It is a questionnaire with 21 items whose intensity ranges from 0 to 3 points. Largest scores indicate more depressive symptoms.
Before the treatment, up to 3, 6 and 18 weeks
Symptoms and adverse events
Time Frame: Before the treatment, up to 3, 6 and 18 weeks
The record of the symptoms and adverse events that occurred during the established behavior will be captured passively through spontaneous reports of the patient. The active catch will use a questionnaire with a record of the duration and intensity of the adverse symptom reported by the patient. You will then be asked to the patient graduates the certainty of their affirmations according to a Likert scale (being 1 not certain and 5 total certainty).
Before the treatment, up to 3, 6 and 18 weeks
Patient Satisfaction: The MedRisk scale
Time Frame: Patients will be evaluated up to 6 weeks
The MedRisk scale consists of 20 items, 10 items related to the therapist-patient interaction; 8 items involving evaluation of the infrastructure and work organization of the physical therapy clinic and 2 items that are considered as global evaluation of the treatment. The patient elects level of satisfaction in each item by selecting a Likert scale ranging from 1 "completely disagree" to 5 "agree completely" or through an option "not applicable", with high scores representing high satisfaction.
Patients will be evaluated up to 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Raquel A Casarotto, PhD, University of Sao Paulo
  • Principal Investigator: Sandra Amaral, Bachelor, University of Sao Paulo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2018

Primary Completion (Actual)

September 30, 2020

Study Completion (Actual)

September 30, 2020

Study Registration Dates

First Submitted

April 15, 2019

First Submitted That Met QC Criteria

August 6, 2019

First Posted (Actual)

August 7, 2019

Study Record Updates

Last Update Posted (Actual)

October 5, 2020

Last Update Submitted That Met QC Criteria

October 1, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Pilates and Shortwave placebo

3
Subscribe